Michael Soeberdt

832 total citations
33 papers, 510 citations indexed

About

Michael Soeberdt is a scholar working on Dermatology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael Soeberdt has authored 33 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Dermatology, 9 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael Soeberdt's work include Dermatology and Skin Diseases (14 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Receptor Mechanisms and Signaling (5 papers). Michael Soeberdt is often cited by papers focused on Dermatology and Skin Diseases (14 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Receptor Mechanisms and Signaling (5 papers). Michael Soeberdt collaborates with scholars based in Germany, United States and Hungary. Michael Soeberdt's co-authors include Christoph Abels, Ana Kilić, Nuri Gueven, Achim Feurer, Michael A. Erb, Christian Rummey, Bernhard Wünsch, Andrea Chicca, Jürg Gertsch and Dirk Schepmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Michael Soeberdt

32 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Soeberdt Germany 12 191 124 121 74 65 33 510
Silvia Pontis Italy 15 271 1.4× 157 1.3× 228 1.9× 20 0.3× 73 1.1× 30 745
Shayan Modarres United States 9 185 1.0× 115 0.9× 72 0.6× 42 0.6× 196 3.0× 10 560
Hidetaka Nagata Japan 14 145 0.8× 40 0.3× 78 0.6× 136 1.8× 51 0.8× 25 609
Naotaka Izuo Japan 14 234 1.2× 82 0.7× 92 0.8× 36 0.5× 206 3.2× 38 560
Éva Sághy Hungary 14 172 0.9× 131 1.1× 32 0.3× 17 0.2× 130 2.0× 23 548
Filomena Lauro Italy 13 201 1.1× 88 0.7× 49 0.4× 15 0.2× 263 4.0× 20 568
Mei‐Mei Gao China 16 319 1.7× 50 0.4× 132 1.1× 23 0.3× 70 1.1× 33 644
Vadim N. Dedov Australia 11 242 1.3× 114 0.9× 31 0.3× 18 0.2× 118 1.8× 17 603
Wenling Dai China 16 196 1.0× 114 0.9× 75 0.6× 6 0.1× 214 3.3× 29 525

Countries citing papers authored by Michael Soeberdt

Since Specialization
Citations

This map shows the geographic impact of Michael Soeberdt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Soeberdt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Soeberdt more than expected).

Fields of papers citing papers by Michael Soeberdt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Soeberdt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Soeberdt. The network helps show where Michael Soeberdt may publish in the future.

Co-authorship network of co-authors of Michael Soeberdt

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Soeberdt. A scholar is included among the top collaborators of Michael Soeberdt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Soeberdt. Michael Soeberdt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Póliska, Szilárd, Judit Váradi, Dezső Tóth, et al.. (2025). Fluoxetine exerts anti-proliferative effect in human epidermal keratinocytes. Archives of Dermatological Research. 317(1). 277–277. 1 indexed citations
2.
Kragl, Martin, T. Braun, Przemyslaw A. Filipek, et al.. (2024). An oil-in-water emulsion containing a combination of ginger extract and synthetic cannabidiol with potent in vitro anti-inflammatory effects alleviates symptoms of atopic dermatitis in a clinical trial. European Journal of Dermatology. 34(4). 416–424. 2 indexed citations
3.
Braun, T., Shah Hussain, Thomas Jakschitz, et al.. (2024). Anti-inflammatory and cytoprotective polypharmacology of Canephron N reveals targeting of the IKK-NF-κB and p38-MK2-RIPK1 axes. Biomedicine & Pharmacotherapy. 182. 117747–117747.
4.
Bı́ró, Tamás, Jennifer I. Drake, Alison O’Mahony, et al.. (2023). Fluoxetine exerts anti‐inflammatory effects on human epidermal keratinocytes and suppresses their endothelin release. Experimental Dermatology. 33(1). e14988–e14988. 2 indexed citations
5.
Abels, Christoph, Michael Soeberdt, Ana Kilić, et al.. (2021). A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial*. British Journal of Dermatology. 185(2). 315–322. 17 indexed citations
6.
Soeberdt, Michael, Ana Kilić, & Christoph Abels. (2020). Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis. European Journal of Pharmacology. 881. 173242–173242. 13 indexed citations
7.
Proksch, Ehrhardt, et al.. (2019). Influence of Buffers of Different pH and Composition on the Murine Skin Barrier, Epidermal Proliferation, Differentiation, and Inflammation. Skin Pharmacology and Physiology. 32(6). 328–336. 10 indexed citations
8.
Marsella, Rosanna, et al.. (2019). Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles. Archives of Dermatological Research. 311(10). 795–800. 7 indexed citations
9.
Chabicovsky, Monika, et al.. (2019). Pharmacology, toxicology and clinical safety of glycopyrrolate. Toxicology and Applied Pharmacology. 370. 154–169. 44 indexed citations
10.
Abels, Christoph & Michael Soeberdt. (2019). Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases. Experimental Dermatology. 28(9). 1002–1009. 17 indexed citations
11.
Proksch, Ehrhardt, et al.. (2018). 670 Topically applied buffers of different pH and composition influence skin pH, barrier repair, epidermal differentiation, and inflammation. Journal of Investigative Dermatology. 138(5). S114–S114. 2 indexed citations
12.
Soeberdt, Michael, Clarissa Masur, U. Knie, Dieter Metze, & Christoph Abels. (2018). 388 A phase Ib trial in AD patients evaluating safety, tolerability, pharmacokinetics and efficacy of topical formulations containing the kappa-opioid receptor agonist WOL071-007. Journal of Investigative Dermatology. 138(5). S66–S66. 2 indexed citations
13.
Kilić, Ana, et al.. (2017). 126 The selective serotonin reuptake inhibitor fluoxetine exerts anti-inflammatory actions on human epidermal keratinocytes. Journal of Investigative Dermatology. 137(10). S214–S214. 1 indexed citations
14.
Oláh, Attila, Michael Soeberdt, U. Knie, et al.. (2017). Echinacea purpurea -derived alkylamides exhibit potent anti-inflammatory effects and alleviate clinical symptoms of atopic eczema. Journal of Dermatological Science. 88(1). 67–77. 50 indexed citations
15.
Soeberdt, Michael, et al.. (2016). Synthesis and pharmacological evaluation of conformationally restricted κ-opioid receptor agonists. MedChemComm. 7(12). 2368–2380. 6 indexed citations
16.
Klenner, Lars, Christoph Baumann, Matteo Auriemma, et al.. (2016). The tripeptide KdPT ameliorates ongoing psoriasis‐like skin inflammation in murine and human skin. Experimental Dermatology. 26(4). 328–334. 6 indexed citations
17.
Molenveld, Peter, Geert Jan Sterk, Reshma Autar, et al.. (2015). Conformationally restricted κ-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines. Bioorganic & Medicinal Chemistry Letters. 25(22). 5326–5330. 9 indexed citations
18.
Nicolussi, Simon, et al.. (2014). Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: From ultrapotent to hyperpotent. Biochemical Pharmacology. 92(4). 669–689. 28 indexed citations
19.
Erb, Michael A., et al.. (2012). Features of Idebenone and Related Short-Chain Quinones that Rescue ATP Levels under Conditions of Impaired Mitochondrial Complex I. PLoS ONE. 7(4). e36153–e36153. 76 indexed citations
20.
Aurich, Hans Günter, Michael Soeberdt, & Klaus Harms. (1999). Formation of enantiopure β-amino alcohols with a 3-oxa-2,7-diazabicyclo[3.3.0]octane framework. Tetrahedron. 55(5). 1249–1270. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026